netFormulary
 Report : A-Z HCD items in Formulary 11/07/2020 15:11:23
[Back]
 
Section Status HCD Name
05.03.01 Restricted Use Cancer Drugs Fund Abacavir 
05.03.01 Restricted Use Cancer Drugs Fund Abacavir and Lamivudine Kivexa®
10.01.03 Restricted Use Cancer Drugs Fund Abatacept  
01.05 Restricted Use Cancer Drugs Fund Adalimumab Gastroenterology
10.01.03 Restricted Use Cancer Drugs Fund Adalimumab Rheumatology
11.04.02 Restricted Use Cancer Drugs Fund Adalimumab Opthalmology
13.05.03 Restricted Use Cancer Drugs Fund Adalimumab Dermatology
20 Non Formulary Cancer Drugs Fund Adalimumab  
20 Restricted Use Cancer Drugs Fund Adalimumab (Immunology) 
11.08.02 Restricted Use Cancer Drugs Fund Aflibercept  Eylea®
09.01.03 Restricted Use Cancer Drugs Fund Antilymphocyte immunoglobulin (rabbit) 
08.02.02 Restricted Use Cancer Drugs Fund Antithymocyte immunoglobulin (rabbit) 
04.09.01 Formulary Cancer Drugs Fund Apomorphine 
10.02 Restricted Use Cancer Drugs Fund Ataluren Translarna
05.03.01 Restricted Use Cancer Drugs Fund Atazanavir .
05.03.01 Restricted Use Cancer Drugs Fund Atazanavir with Cobicistat Evotaz®
05.01 Restricted Use Cancer Drugs Fund Aztreonam Cayston®
08.02.02 Restricted Use Cancer Drugs Fund Basiliximab 
10.01.03 Restricted Use Cancer Drugs Fund Belimumab 
03.04.02 Restricted Use Cancer Drugs Fund Benralizumab Fasenra®
11.08.02 Restricted Use Cancer Drugs Fund Bevacizumab  
05.03.03 Restricted Use Cancer Drugs Fund Boceprevir 
04.07.04.02 Restricted Use Cancer Drugs Fund Botulinum Toxin Type A  
04.09.03 Restricted Use Cancer Drugs Fund Botulinum Toxin Type A  Botox®/ Xeomin®
13.05.03 Restricted Use Cancer Drugs Fund Brodualumab Kyntheum®
08.02.04 Restricted Use Cancer Drugs Fund Canakinumab Ilaris®
10.01.03 Restricted Use Cancer Drugs Fund Certolizumab pegol 
13.05.03 Restricted Use Cancer Drugs Fund Certolizumab pegol ®
08.02.04 Restricted Use Cancer Drugs Fund Cladribine Mavenclad®
05.03.01 Restricted Use Cancer Drugs Fund Cobicistat  
05.01 Restricted Use Cancer Drugs Fund Colistimethate sodium 
05.01 Restricted Use Cancer Drugs Fund Colistimethate sodium  Colobreathe®
10.03.01 Restricted Use Cancer Drugs Fund Collagenase  
05.03.03 Restricted Use Cancer Drugs Fund Daclatasvir  
09.01.03 Restricted Use Cancer Drugs Fund Darbepoetin Alfa  Aranesp®
05.03.01 Restricted Use Cancer Drugs Fund Darunavir 
05.03.01 Restricted Use Cancer Drugs Fund Darunavir with Cobicistat Rezolsta®
05.03.03 Restricted Use Cancer Drugs Fund Dasabuvir  
09.01.03 Restricted Use Cancer Drugs Fund Deferasirox Exjade®
09.01.03 Restricted Use Cancer Drugs Fund Deferiprone Ferriprox®
09.01.03 Restricted Use Cancer Drugs Fund Desferrioxamine mesilate 
11.04.01 Restricted Use Cancer Drugs Fund Dexamethasone Intravitreal Implant  Ozurdex®
05.03.01 Restricted Use Cancer Drugs Fund Didanosine 
05.03.01 Restricted Use Cancer Drugs Fund Dolutegravir 
05.03.01 Restricted Use Cancer Drugs Fund Dolutegravir & lamivudine Dovato®
05.03.01 Restricted Use Cancer Drugs Fund Dolutegravir, Abacavir and Lamivudine Triumeq®
05.03.01 Restricted Use Cancer Drugs Fund Dolutegravir, Rilpivirine Juluca®
05.03.01 Restricted Use Cancer Drugs Fund Doravirine Pifeltro®
13.05 Restricted Use Cancer Drugs Fund Dupilumab Dupixent®
05.03.01 Restricted Use Cancer Drugs Fund Efavirenz, Emtricitabine and Tenofovir Disoproxil Atripla®
05.03.03 Restricted Use Cancer Drugs Fund Elbasvir and grazoprevir Zepatier®
09.01.04 Restricted Use Cancer Drugs Fund Eltrombopag 
05.03.01 Restricted Use Cancer Drugs Fund Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide  Genvoya®
05.03.01 Restricted Use Cancer Drugs Fund Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Disoproxil  Stribild®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine 
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine and Tenofovir Alafenamide Descovy®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine, Rilpivirine and Tenofovir Alafenamide Odefsey®
05.03.01 Restricted Use Cancer Drugs Fund Emtricitabine, Rilpivirine and Tenofovir Disoproxil  Eviplera®
05.03.01 Restricted Use Cancer Drugs Fund Enfuvirtide 
05.03.03 Restricted Use Cancer Drugs Fund Entecavir  
09.01.03 Restricted Use Cancer Drugs Fund Epoetin alfa 
09.01.03 Restricted Use Cancer Drugs Fund Epoetin beta 
10.01.03 Restricted Use Cancer Drugs Fund Etanercept  Erelzi® Rheumatology
13.05.03 Restricted Use Cancer Drugs Fund Etanercept  Erelzi ® Dermatology
09.05.01.02 Formulary Cancer Drugs Fund Etelcalcetide Parsabiv®
02.12 Restricted Use Cancer Drugs Fund Evolocumab  Repatha®
09.01.06 Restricted Use Cancer Drugs Fund Filgrastim  
11.04.01 Restricted Use Cancer Drugs Fund Fluocinolone acetonide intravitreal implant  Iluvien
20 Restricted Use Cancer Drugs Fund Fomepizole  
05.03.01 Restricted Use Cancer Drugs Fund Fosamprenavir 
05.03.03 Restricted Use Cancer Drugs Fund Glecaprevir and pibrentasvir Maviret®
10.01.03 Restricted Use Cancer Drugs Fund Golimumab  
13.05.03 Restricted Use Cancer Drugs Fund Guselkumab 
20 Restricted Use Cancer Drugs Fund Infliximab (Immunology) 
01.05 Restricted Use Cancer Drugs Fund Infliximab (Inflectra®) Gastroenterology
10.01.03 Restricted Use Cancer Drugs Fund Infliximab (Inflectra®) Rheumatology
13.05.03 Restricted Use Cancer Drugs Fund Infliximab (Inflectra®) Dermatology
08.02.04 Formulary Cancer Drugs Fund Interferon beta-1a Rebif®
03.07 Restricted Use Cancer Drugs Fund Ivacaftor  
13.05.03 Restricted Use Cancer Drugs Fund Ixekizumab  
05.03.01 Restricted Use Cancer Drugs Fund Lamivudine 
08.03.04.03 Restricted Use Cancer Drugs Fund Lanreotide  
05.03.03 Restricted Use Cancer Drugs Fund Ledipasvir and sofosbuvir  Harvoni®
09.01.06 Restricted Use Cancer Drugs Fund Lenograstim 
05.03.01 Restricted Use Cancer Drugs Fund Lopinavir with Ritonavir 
03.07 Restricted Use Cancer Drugs Fund Lumacaftor/ Ivacaftor  Orkambi®
05.03.01 Restricted Use Cancer Drugs Fund Maraviroc 
03.04.02 Restricted Use Cancer Drugs Fund Mepolizumab Nucala®
10.01.03 Restricted Use Cancer Drugs Fund Methotrexate  Subcutaneous
13.05.03 Restricted Use Cancer Drugs Fund Methotrexate  Subcutaneous
08.02.04 Restricted Use Cancer Drugs Fund Natalizumab  Tysabri®
03.11 Restricted Use Cancer Drugs Fund Nintedanib 
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin IQYMUNE®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Gammanorm®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Intratect®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Privigen®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Subcuvia 16%®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Hizentra®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Octagam 10%®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Vigam®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Subgam®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Flebogamma®
14.05 Restricted Use Cancer Drugs Fund Normal Immunoglobulin  Gamunex®
02.11 Restricted Use Cancer Drugs Fund NovoSeven® 
01.09.01 Restricted Use Cancer Drugs Fund Obeticholic acid 
08.02.04 Restricted Use Cancer Drugs Fund Ocrelizumab Ocrevus®
11.08.02 Restricted Use Cancer Drugs Fund Ocriplasmin 
08.03.04.03 Restricted Use Cancer Drugs Fund Octreotide  
03.04.02 Restricted Use Cancer Drugs Fund Omalizumab Xolair®
05.03.03 Restricted Use Cancer Drugs Fund Ombitasvir, paritaprevir, and ritonavir  Viekirax®
03.11 Restricted Use Cancer Drugs Fund Pirfenidone  
09.01.07 Restricted Use Cancer Drugs Fund Plerixafor  
05.03.01 Restricted Use Cancer Drugs Fund Raltegravir 
11.08.02 Restricted Use Cancer Drugs Fund Ranibizumab  Lucentis®
10.01.04 Restricted Use Cancer Drugs Fund Rasburicase 
03.04.02 Restricted Use Cancer Drugs Fund Reslizumab Cinqaero®
04.09.03 Formulary Cancer Drugs Fund Riluzole Rilutek®
13.05.03 Restricted Use Cancer Drugs Fund Risankizumab Skyrizi®
05.03.01 Restricted Use Cancer Drugs Fund Ritonavir .
13.05.03 Restricted Use Cancer Drugs Fund Rituximab 
10.01.03 Restricted Use Cancer Drugs Fund Rituximab (Truxima®) Rheumatology
09.01.04 Restricted Use Cancer Drugs Fund Romiplostim 
10.01.03 Restricted Use Cancer Drugs Fund Sarilumab Kevzera®
10.01.03 Restricted Use Cancer Drugs Fund Secukinumab 
13.05.03 Restricted Use Cancer Drugs Fund Secukinumab  Dermatology
05.03.03 Restricted Use Cancer Drugs Fund Simeprevir 
04.01.01 Restricted Use Cancer Drugs Fund Sodium Oxybate 
05.03.03 Restricted Use Cancer Drugs Fund Sofosbuvir 
05.03.03 Restricted Use Cancer Drugs Fund Sofosbuvir, velpatasvir, voxilaprevir Vosevi®
05.03.03 Restricted Use Cancer Drugs Fund Sofosbuvir/valpatasvir Epclusa®
09.05.02.02 Restricted Use Cancer Drugs Fund Sucroferric oxyhydroxide Velphoro®
17 Restricted Use Cancer Drugs Fund TachoSil  
08.02.02 Restricted Use Cancer Drugs Fund Tacrolimus Adoport®, Prograf® or Modigraf®
08.02.02 Restricted Use Cancer Drugs Fund Tacrolimus SR Envarsus®
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir Disoproxil .
05.03.01 Restricted Use Cancer Drugs Fund Tenofovir Disoproxil and Emtricitabine Truvada®
08.02.04 Restricted Use Cancer Drugs Fund Teriflunomide  Aubagio®
06.06.02 Restricted Use Cancer Drugs Fund Teriparatide  
03.07 Restricted Use Cancer Drugs Fund Tezacaftor/ Ivacaftor Symkevi®
05.03.01 Restricted Use Cancer Drugs Fund Tipranavir .
05.01 Restricted Use Cancer Drugs Fund Tobramycin  Bramitob®
05.01 Restricted Use Cancer Drugs Fund Tobramycin  Tobi ® podhaler
10.01.03 Restricted Use Cancer Drugs Fund Tocilizumab  
01.05 Restricted Use Cancer Drugs Fund Tofacitinib XELJANZ®
10.01.03 Restricted Use Cancer Drugs Fund Tofacitinib XELJANZ®
06.05.02 Restricted Use Cancer Drugs Fund Tolvaptan 
13.05.03 Restricted Use Cancer Drugs Fund Ustekinumab Dermatology
10.01.03 Restricted Use Cancer Drugs Fund Ustekinumab (Rheumatology) 
05.03.01 Restricted Use Cancer Drugs Fund Zidovudine 
05.03.01 Restricted Use Cancer Drugs Fund Zidovudine and Lamivudine 
Leicestershire Health Community